THE NATIONAL CONSENSUS PROJECT* «CYSTIC FIBROSIS: DEFINITION, DIAGNOSTIC CRITERIA, AND THERAPY». SECTION «INHALATION THERAPY» (ABRIDGED)

• Egile Nagusiak: Ye. L. Amelina (Egilea), I. K. Asherova (Egilea), I. K. Volkov (Egilea), Т. Ye. Gembitskaya (Egilea), Ye. K. Ginter (Egilea), N. А. Il'yenkova (Egilea), N. I. Kapranov (Egilea), I. P. Karimova (Egilea), N. Yu. Kashirskaya (Egilea), Ye. I. Kondrat'yeva (Egilea), М. N. Kostyleva (Egilea), S. А. Krasovsky (Egilea), N. B. Merzlova (Egilea), L. P. Nazarenko (Egilea), L. S. Namazova-Baranova (Egilea), А. F. Neretina (Egilea), V. S. Nikonova (Egilea), А. V. Orlov (Egilea), S. S. Postnikov (Egilea), Т. А. Protasova (Egilea), S. Yu. Semykin (Egilea), D. F. Sergienko (Egilea), О. I. Simonova (Egilea), I. D. Uspenskaya (Egilea), М. Yu. Chernukha (Egilea), L. А. Shabalova (Egilea), I. А. Shaginyan (Egilea), V. D. Sherman (Egilea)
• Formatua: Liburua
• Argitaratua: "Paediatrician" Publishers LLC, 2014-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including glucocorticoids, recommended for use in cystic fibrosis...